The 2023 World Summit for microphysiological systems (MPS) had a record attendence with over 1,200 participants from all over the world. The increase of attendees from 700 at the 2022 MPS Meeting in New Orleans showed the dynamics in this emerging field. 196 speakers reported on their research using organs-on-chip.
The conference started with a very successful Educational Workshop where VITROCELL explained the exposure to the AlveoliX AX12 lung-on-chip using the exposure system Cloud Alpha AlveoliX AX12.
Clémentine Richter from the Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany presented her poster on alveolar inflammation illustrating human drug response using the Cloud Alpha AlveoliX AX12 (See Poster)
The exhibition gave an excellent overview on all current technologies. As a conclusion, VITROCELL Systems GmbH and AlveoliX AG have a definite leading position in turnkey lung-on-chip solutions for direct and controlled Aerosol Exposure at the Air/Liquid Interface.
The conference started with a very successful Educational Workshop where VITROCELL explained the exposure to the AlveoliX AX12 lung-on-chip using the exposure system Cloud Alpha AlveoliX AX12.
Clémentine Richter from the Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany presented her poster on alveolar inflammation illustrating human drug response using the Cloud Alpha AlveoliX AX12 (See Poster)
The exhibition gave an excellent overview on all current technologies. As a conclusion, VITROCELL Systems GmbH and AlveoliX AG have a definite leading position in turnkey lung-on-chip solutions for direct and controlled Aerosol Exposure at the Air/Liquid Interface.
